What are the best treatments for Endometrial cancer?

The primary treatment for endometrial cancer is surgery, typically a hysterectomy with bilateral salpingo-oophorectomy, often followed by radiation or chemotherapy depending on the cancer stage and grade. Because endometrial cancer treatment must be highly personalized based on molecular profiling and tumor characteristics, patients should consult with a gynecologic oncologist to determine the most effective strategy for their specific diagnosis.

What are the standard treatments for endometrial cancer?

For most patients with early-stage endometrial cancer, surgery is the cornerstone of care. Depending on the pathology, adjuvant therapies may be required to reduce the risk of recurrence. Treatment protocols are generally divided into the following categories:

• Surgical intervention: Hysterectomy (removal of the uterus) and removal of the fallopian tubes and ovaries.


• Radiation therapy: External beam radiation or brachytherapy (internal radiation) to target the pelvic area.


• Systemic therapy: Chemotherapy (e.g., carboplatin, paclitaxel) or hormone therapy (e.g., medroxyprogesterone acetate, megestrol acetate) for advanced or recurrent cases.


• Immunotherapy: Checkpoint inhibitors like pembrolizumab (Keytruda) for patients with specific biomarkers such as microsatellite instability-high (MSI-H).

How is a care team structured for endometrial cancer?

Managing endometrial cancer requires a multidisciplinary team to address both physical and emotional needs. Key specialists include gynecologic oncologists, radiation oncologists, medical oncologists, and pathologists. Additionally, clinical psychologists or oncology social workers are vital for supporting patients through the diagnosis and survivorship journey, as noted by the 31 members currently sharing their experiences on DiseaseMaps.org.

What is the role of emerging therapies?

The landscape for endometrial cancer is evolving rapidly with the integration of molecular classification (e.g., POLE-mutated, mismatch repair-deficient). Clinical trials are currently investigating targeted therapies and antibody-drug conjugates to improve outcomes for patients with aggressive or recurrent disease. Participation in clinical trials can offer access to these cutting-edge treatments.

Next steps

• Consult with a board-certified gynecologic oncologist to discuss your specific tumor grade and stage.


• Ask your medical team about molecular and genetic testing, which can guide personalized therapy.


• Connect with the endometrial cancer community at DiseaseMaps.org to share experiences and find support.


• Maintain regular follow-up appointments, as monitoring is critical for long-term health.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with your healthcare team regarding your specific treatment plan.

References

• National Cancer Institute (NCI) - Endometrial Cancer PDQ


• NIH Genetic and Rare Diseases Information Center (GARD)


• American College of Obstetricians and Gynecologists (ACOG) guidelines


• Foundation for Women's Cancer